SPP1 and prostate carcinoma: For instance, a FET-CNT immunosensor was developed for detection of osteopontin (OPN), a biomarker of prostate cancer by attaching a genetically-engineered single chain variable fragment protein with high binding affinity for OPN, and employed to monitor this biomarker in a background of concentrated bovine serum albumin (Lerner et al., 2012).